Advertisement
"We are very pleased to announce Mike's election to the StereotaxisBoard," said Fred Middleton, Chairman of the Stereotaxis Board of Directors."He continues to play a key role for us in the planning and execution of ourcommercial growth strategy. This will take on increasing significance atStereotaxis as we prepare to expand the utilization of our innovativetechnology through several new product introductions into what is becoming anexpanding world-wide market."
Advertisement
Bevil Hogg, Chief Executive Officer for Stereotaxis, added, "Under Mike'soperational leadership, Stereotaxis has successfully positioned itself as aleader in innovative interventional robotic systems. He will strengthen ourfocus on building Stereotaxis into a successful commercial enterprise from anearly stage technology company."
Mr. Kaminski joined Stereotaxis in April 2002 as its Chief OperatingOfficer. He was named to the additional position of President in 2007. Priorto joining the Company, Mr. Kaminski spent nearly 20 years with Hill-RomCompany, a leading worldwide manufacturer and provider of medical technologiesand related services for the health care industry. In his last position thereas Senior Vice President of North American Sales and Service, he wasresponsible for 150 service centers, and revenue exceeding $750 million. Mr.Kaminski began his career at Hill-Rom in a manufacturing management positionand then worked in several functional departments, including sales, marketing,purchasing, new product development, and general management of multiplebusinesses. Mr. Kaminski has an M.B.A. from Xavier University and a B.S. inMarketing from Indiana University.
About Stereotaxis
Stereotaxis designs, manufactures and markets an advanced cardiologyinstrument control system for use in a hospital's interventional surgicalsuite to enhance the treatment of coronary artery disease and arrhythmias. TheStereotaxis System is designed to enable physicians to complete more complexinterventional procedures by providing image guided delivery of catheters andguidewires through the blood vessels and chambers of the heart to treatmentsites. This is achieved using computer-controlled, externally applied magneticfields that govern the motion of the working tip of the catheter or guidewire,resulting in improved navigation, shorter procedure time and reduced x-rayexposure. The core components of the Stereotaxis system have receivedregulatory clearance in the U.S., Europe and Canada.
SOURCE Stereotaxis, Inc.
